4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 99
+0.15
+1.3838%
$
611.63M Market Cap
- P/E Ratio
- Div Yield
598,500 Volume
-3.06 Eps
$ 10.84
Previous Close 
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
FDMT Earnings Reports FAQ
What is the earnings per share (EPS) for FDMT?
The current EPS is -3.06.
What is the company's earnings growth rate?
4D Molecular Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
4D Molecular Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for 4D Molecular Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for FDMT at this time, as 4D Molecular Therapeutics, Inc has no recent EPS data to calculate it.
